Neurostimulation Market - Global Industry Analysis

Neurostimulation Market Therapies (Spinal Cord, Sacral Nerve, Transcranial Magnetic, TENS, Deep Brain, and Vagus Nerve & Gastric), Application (Epilepsy, Urinary & Fecal Incontinence, Dystonia, Parkinson’s Disease, Pain Management, Essential Tremor, Depression, Gastroparesis, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 01-Dec-2020 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-804 Status : Published

According to the report published by Zion Market Research, global demand for Neurostimulation market was valued at approximately USD 7.902 Billion in 2019, and is expected to generate revenue of around USD 18.014 Billion by end of 2026, growing at a CAGR of around 15.13% between 2020 and 2026.

Description

According to the report published by Zion Market Research, global demand for Neurostimulation market was valued at approximately USD 7.902 Billion in 2019, and is expected to generate revenue of around USD 18.014 Billion by end of 2026, growing at a CAGR of around 15.13% between 2020 and 2026.

Global Neurostimulation Market: Overview

The treatment of various illnesses such as incontinence, epilepsy, essential tremors, gastroparesis, Parkinson’s disease and depression use neurostimulation. Neurostimulation is a high potential treatment in which the patients find relief from their pain, which is not obtained by surgical therapies and medications. The life quality of the patients, who are paralyzed or suffering from loss of the sense organs, is improved highly. Hence, neurostimulation is highly influential in hearing aids, artificial vision, artificial limbs and others.

Global Neurostimulation Market: Growth Factors

The global neurostimulation market is growing tremendously. The pain management application is the largest application of the global market. The rise in the occurrences of chronic pain and increase in the usage of neurostimulation therapies are some of the factors that are driving the global market growth. The sacral nerve stimulators segment is also rapidly growing. This growth is owing to the rise in the patients with fecal and urinary incontinence. The other factors that are driving the global market growth are the rise in the aging population that is having neurological disorders and the need for neurological care. Developments in the neurology have been observed owing to the rising awareness among people about the enhanced clinical outcomes. The other reason for the global market growth is the rise in the diseases such as epilepsy and migraine, Alzheimer’s and the Parkinson’s which in turn increases the demand for the neurostimulation devices. Various technological advancements and researchers have contributed a major share in the global neurostimulation market growth.

Global Neurostimulation Market

Global Neurostimulation Market: Segmentation

The global neurostimulation market is segmented on the basis of the therapies, application, and regions. On the basis of the therapies, the global market is categorized into the spinal cord, sacral nerve, transcranial magnetic, TENS, deep brain, vagus nerve and gastric. Based on the applications, the global neurostimulation market is segregated into epilepsy, urinary and fecal incontinence, dystonia, Parkinson’s disease, pain management, essential tremor, depression, gastroparesis, and others.

Region-wise, the global market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global Neurostimulation Market: Regional Analysis

The global neurostimulation market is standing strong in the North American region which is followed by Europe and Asia-Pacific. The growth in the Asia-Pacific region is tremendously fast especially in countries such as India, China, and Brazil. The growth in this region is mainly owing to the growing awareness among people about neurostimulation, which acts as an alternative treatment for the neurological disorders and the chronic pain. In the North American region, the U.S. contributes the largest share in the global neurostimulation market growth, which is followed by Germany. The factors that are contributing to the global market growth are the advanced healthcare infrastructure and the high occurrences of diseases such as a migraine, Alzheimer’s, epilepsy, Parkinson’s disease.

Global Neurostimulation Market: Competitive Players

Some main participants of the Neurostimulation market are Cyberonics Inc., Medtronic Inc., CVRx Inc., Boston Scientific Corp., St. Jude Medical Inc., and Neuropace Inc. Other major players in the global market include Aleva Neurotherapeutics SA, Bioness Inc., EnteroMedics Inc., NeuroSigma Inc., BioControl Medical, LivaNova PLC, and Synapse Biomedical Inc, among others.

Neurostimulation Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1.Preface
    • 1.1.Report Description
    • 1.2.Report Scope
  • Chapter 2.Research Methodology
    • 2.1.Research Methodology
    • 2.2.Secondary Research
    • 2.3.Primary Research
    • 2.4.Models
      • 2.4.1.Company Share Analysis Model
      • 2.4.2.Revenue Based Modeling
    • 2.5.Research Limitations
  • Chapter 3.Executive Summary
    • 3.1.Global Neurostimulation Market, 2016 – 2026 (USD Billion)
    • 3.2.Global Neurostimulation Market: Snapshot
  • Chapter 4.Neurostimulation Market – Industry Analysis
    • 4.1.Introduction
    • 4.2.Market Drivers
      • 4.2.1.Driving Factor 1 Analysis
      • 4.2.2.Driving Factor 2 Analysis:
    • 4.3.Market Restraints
      • 4.3.1.Restraining Factor Analysis
    • 4.4.Market Opportunities
      • 4.4.1.Market Opportunity & Use-case Anaysis
      • 4.4.2.Use – Cases for Neurostimulation
    • 4.5.Porter’s Five Forces Analysis
    • 4.6.COVID 19 Impact Analysis
      • 4.6.1.1.Impact on Product Development and Technology Adoption
      • 4.6.1.2.Gap Analysis
  • Chapter 5.Investment Proposition Analysis
    • 5.1.Global Neurostimulation Market Attractiveness, By Therapies
    • 5.2.Global Neurostimulation Market Attractiveness, By Application
    • 5.3.Global Neurostimulation Market Attractiveness, By Region
  • Chapter 6.Competitive Landscape
    • 6.1.Company Market Share Analysis - 2019
      • 6.1.1.Global Neurostimulation Market: Company Market Share, 2019
    • 6.2.Strategic Developments
    • 7.1.Global Neurostimulation Market Overview: by Therapies
      • 7.1.1.Global Neurostimulation Market Revenue Share, by Therapies, 2019 & 2026
    • 7.2.Global Neurostimulation Market Analysis/Overview – By Therapies
      • 7.2.1.Spinal Cord – Overview/Analysis
      • 7.2.2.Sacral Nerve – Overview/Analysis
      • 7.2.3.Transcranial Magnetic – Overview/Analysis
      • 7.2.4.TENS – Overview/Analysis
      • 7.2.5.Deep Brain – Overview/Analysis
      • 7.2.6.Vagus Nerve & Gastric – Overview/Analysis
    • 7.3.Spinal Cord
      • 7.3.1.Global Neurostimulation Market for Spinal Cord, Revenue (USD Billion) 2016 - 2026
    • 7.4.Sacral Nerve
      • 7.4.1.Global Neurostimulation Market for Sacral Nerve, Revenue (USD Billion) 2016 - 2026
    • 7.5.Transcranial Magnetic
      • 7.5.1.Global Neurostimulation Market for Transcranial Magnetic, Revenue (USD Billion) 2016 - 2026
    • 7.6.TENS
      • 7.6.1.Global Neurostimulation Market for TENS, Revenue (USD Billion) 2016 - 2026
    • 7.7.Deep Brain
      • 7.7.1.Global Neurostimulation Market for Deep Brain, Revenue (USD Billion) 2016 - 2026
    • 7.8.Vagus Nerve & Gastric
      • 7.8.1.Global Neurostimulation Market for Vagus Nerve & Gastric, Revenue (USD Billion) 2016 - 2026
    • 8.1.Global Neurostimulation Market Overview: by Application
      • 8.1.1.Global Neurostimulation Market Revenue Share, by Application, 2019 & 2026
    • 8.2.Global Neurostimulation Market Analysis/Overview – By Application
      • 8.2.1.Epilepsy – Overview/Analysis
      • 8.2.2.Urinary & Fecal Incontinence – Overview/Analysis
      • 8.2.3.Dystonia – Overview/Analysis
      • 8.2.4.Parkinson’s Disease – Overview/Analysis
      • 8.2.5.Pain Management – Overview/Analysis
      • 8.2.6.Essential Tremor – Overview/Analysis
      • 8.2.7.Depression – Overview/Analysis
      • 8.2.8.Gastroparesis – Overview/Analysis
      • 8.2.9.Others – Overview/Analysis
    • 8.3.Epilepsy
      • 8.3.1.Global Neurostimulation Market for Epilepsy, Revenue (USD Billion) 2016 - 2026
    • 8.4.Urinary & Fecal Incontinence
      • 8.4.1.Global Neurostimulation Market for Urinary & Fecal Incontinence, Revenue (USD Billion) 2016 - 2026
    • 8.5.Dystonia
      • 8.5.1.Global Neurostimulation Market for Dystonia, Revenue (USD Billion) 2016 - 2026
    • 8.6.Parkinson’s Disease
      • 8.6.1.Global Neurostimulation Market for Parkinson’s Disease, Revenue (USD Billion) 2016 - 2026
    • 8.7.Pain Management
      • 8.7.1.Global Neurostimulation Market for Pain Management, Revenue (USD Billion) 2016 - 2026
    • 8.8.Essential Tremor
      • 8.8.1.Global Neurostimulation Market for Essential Tremor, Revenue (USD Billion) 2016 - 2026
    • 8.9.Depression
      • 8.9.1.Global Neurostimulation Market for Depression, Revenue (USD Billion) 2016 - 2026
    • 8.1.Gastroparesis
      • 8.10.1.Global Neurostimulation Market for Gastroparesis, Revenue (USD Billion) 2016 - 2026
    • 8.11.Others
      • 8.11.1.Global Neurostimulation Market for Others, Revenue (USD Billion) 2016 - 2026
  • Chapter 9.Neurostimulation Market – Regional Analysis
    • 9.1.Global Neurostimulation Market: Regional Overview
      • 9.1.1.Global Neurostimulation Market Revenue Share, by Region, 2019 & 2026
      • 9.1.2.Global Neurostimulation Market Revenue, by Region, 2016 – 2026 (USD Billion)
    • 9.2.North America
      • 9.2.1.North America Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.2.2.North America Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.2.3.North America Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.2.4.North America Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.2.5. U.S.
      • 9.2.6.Canada
    • 9.3.Europe
      • 9.3.1.Europe Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.3.2.Europe Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.3.3.Europe Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.3.4.Europe Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.3.5.Germany
      • 9.3.6.France
      • 9.3.7. U.K.
      • 9.3.8.Italy
      • 9.3.9.Spain
      • 9.3.10.Rest of Europe
    • 9.4.Asia Pacific
      • 9.4.1.Asia Pacific Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.4.2.Asia Pacific Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.4.3.Asia Pacific Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.4.4.Asia Pacific Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.4.5.China
      • 9.4.6.Japan
      • 9.4.7.India
      • 9.4.8.South Korea
      • 9.4.9.South-East Asia
      • 9.4.10.Rest of Asia Pacific
    • 9.5.Latin America
      • 9.5.1.Latin America Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.5.2.Latin America Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.5.3.Latin America Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.5.4.Latin America Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.5.5.Brazil
      • 9.5.6.Mexico
      • 9.5.7.Rest of Latin America
    • 9.6.The Middle-East and Africa
      • 9.6.1.The Middle-East and Africa Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
      • 9.6.2.The Middle-East and Africa Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
      • 9.6.3.The Middle-East and Africa Neurostimulation Market Revenue, by Therapies, 2016 – 2026
      • 9.6.4.The Middle-East and Africa Neurostimulation Market Revenue, by Application, 2016 – 2026
      • 9.6.5.GCC Countries
      • 9.6.6.South Africa
      • 9.6.7.Rest of Middle-East Africa
  • Chapter 10.Company Profiles
    • 10.1.Cyberonics Inc.
      • 10.1.1.Company Overview
      • 10.1.2.Financial Overview
      • 10.1.3.Product Portfolio
      • 10.1.4.Business Strategy
      • 10.1.5.Recent Developments
    • 10.2.Medtronic Inc.
    • 10.3.CVRx Inc.
    • 10.4.Boston Scientific Corp.
    • 10.5.St. Jude Medical Inc.
    • 10.6.Neuropace Inc.
    • 10.7.Aleva Neurotherapeutics SA
    • 10.8.Bioness Inc.
    • 10.9.EnteroMedics Inc.
    • 10.1.NeuroSigma Inc.
    • 10.11.BioContrul Medical
    • 10.12.LivaNova PLC
    • 10.13.Synapse Biomedical Inc
    • 10.14.Others

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 5 Porter’s Five Forces Analysis for Global Neurostimulation Market
FIG. 6 Global Neurostimulation Market Attractiveness, By Therapies
FIG. 7 Global Neurostimulation Market Attractiveness, By Application
FIG. 8 Global Neurostimulation Market Attractiveness, By End-User
FIG. 9 Company Share Analysis, 2019
FIG. 10 Global Neurostimulation Market Revenue Share, by Therapies, 2019 & 2026
FIG. 11 Global Neurostimulation Market for Spinal Cord, Revenue (USD Billion) 2016 - 2026
FIG. 12 Global Neurostimulation Market for Sacral Nerve, Revenue (USD Billion) 2016 - 2026
FIG. 13 Global Neurostimulation Market for Transcranial Magnetic, Revenue (USD Billion) 2016 - 2026
FIG. 14 Global Neurostimulation Market for TENS, Revenue (USD Billion) 2016 - 2026
FIG. 15 Global Neurostimulation Market for Deep Brain, Revenue (USD Billion) 2016 - 2026
FIG. 16 Global Neurostimulation Market for Vagus Nerve & Gastric, Revenue (USD Billion) 2016 - 2026
FIG. 17 Global Neurostimulation Market Revenue Share, by Application, 2019 & 2026
FIG. 18 Global Neurostimulation Market for Epilepsy, Revenue (USD Billion) 2016 - 2026
FIG. 19 Global Neurostimulation Market for Urinary & Fecal Incontinence, Revenue (USD Billion) 2016 - 2026
FIG. 20 Global Neurostimulation Market for Dystonia, Revenue (USD Billion) 2016 - 2026
FIG. 21 Global Neurostimulation Market for Parkinson’s Disease, Revenue (USD Billion) 2016 - 2026
FIG. 22 Global Neurostimulation Market for Pain Management, Revenue (USD Billion) 2016 - 2026
FIG. 23 Global Neurostimulation Market for Essential Tremor, Revenue (USD Billion) 2016 - 2026
FIG. 24 Global Neurostimulation Market for Depression, Revenue (USD Billion) 2016 - 2026
FIG. 25 Global Neurostimulation Market for Gastroparesis, Revenue (USD Billion) 2016 - 2026
FIG. 26 Global Neurostimulation Market for Others, Revenue (USD Billion) 2016 - 2026
FIG. 27 Global Neurostimulation Market Revenue Share, by Region, 2019 & 2026
FIG. 28 North America Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 29 Europe Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 30 Asia Pacific Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 31 Latin America Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 32 The Middle-East and Africa Neurostimulation Market Revenue, 2016 - 2026 (USD Billion)
FIG. 33 Cyberonics Inc. Business Segment Revenue Share, 2018 (%)
FIG. 34 Cyberonics Inc. Geographical Segment Revenue Share, 2018 (%)
 


List of Tables

TABLE 1 Global Neurostimulation Market: Snapshot
TABLE 2 Drivers of the Neurostimulation Market: Impact Analysis
TABLE 3 Restraints for the Neurostimulation Market: Impact Analysis
TABLE 4 Global Neurostimulation Market Revenue, by Region, 2016 – 2026 (USD Billion)
TABLE 5 North America Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 6 North America Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 7 North America Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)
TABLE 8 Europe Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 9 Europe Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 10 Europe Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)
TABLE 11 Asia Pacific Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 12 Asia Pacific Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 13 Asia Pacific Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)
TABLE 14 Latin America Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 15 Latin America Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 16 Latin America Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)
TABLE 17 The Middle-East and Africa Neurostimulation Market Revenue, by Country, 2016 – 2026 (USD Billion)
TABLE 18 The Middle-East and Africa Neurostimulation Market Revenue, by Therapies, 2016 – 2026 (USD Billion)
TABLE 19 The Middle-East and Africa Neurostimulation Market Revenue, by Application, 2016 – 2026 (USD Billion)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global neurostimulation market is growing tremendously. The pain management application is the largest application of the global market. The rise in the occurrences of chronic pain and increase in the usage of neurostimulation therapies are some of the factors that are driving the global market growth. The sacral nerve stimulators segment is also rapidly growing.

According to Zion Market Research, global demand for Neurostimulation market is expected to generate revenue of around USD 18.014 Billion by end of 2026, growing at a CAGR of around 15.13% between 2020 and 2026.

The global neurostimulation market is standing strong in the North American region which is followed by Europe and Asia-Pacific.

Some main participants of the Neurostimulation market are Cyberonics Inc., Medtronic Inc., CVRx Inc., Boston Scientific Corp., St. Jude Medical Inc., and Neuropace Inc. Other major players in the global market include Aleva Neurotherapeutics SA, Bioness Inc., EnteroMedics Inc., NeuroSigma Inc., BioControl Medical, LivaNova PLC, and Synapse Biomedical Inc, among others.

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social